Using CRISPR, researchers in the U.S. have engineered a plasmid to remove an antibiotic resistance gene from the Enterococcus faecalis bacterium.

This breakthrough could lead to new methods for fighting antibiotic resistance – a threat which, on current trends, has the potential to surpass cancer in terms of mortality rate, with more than 10 million deaths each year by 2050. The research appears in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology…”

Read More: